REBIOTIX A FERRING COMPANY Trademark

Trademark Overview


On Friday, January 25, 2019, a trademark application was filed for REBIOTIX A FERRING COMPANY with the United States Patent and Trademark Office. The USPTO has given the REBIOTIX A FERRING COMPANY trademark a serial number of 88276773. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 1, 2021. This trademark is owned by REBIOTIX, INC.. The REBIOTIX A FERRING COMPANY trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders in the fields of gastroenterology, reproductive health, metabolic health, endocrinology; pharmaceutical and biopharmaceutical agents used for the treatment of gastrointestinal, infectious, metabolic, liver, inflammatory and neurological diseases and disorders

Medical and scientific research; providing medical and scientific research information in the field of clinical trials
rebiotix a ferring company

General Information


Serial Number88276773
Word MarkREBIOTIX A FERRING COMPANY
Filing DateFriday, January 25, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 1, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 28, 2019

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"COMPANY"
Description of MarkThe mark consists of a circle formed from six smaller circles positioned above the "b","I", and "o" of the term "rebiotix", with the term "a ferring company" below "rebiotix".
Goods and ServicesPharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders emanating from microbiota dysfunction; pharmaceutical and biopharmaceutical agents used for the treatment of diseases and disorders in the fields of gastroenterology, reproductive health, metabolic health, endocrinology; pharmaceutical and biopharmaceutical agents used for the treatment of gastrointestinal, infectious, metabolic, liver, inflammatory and neurological diseases and disorders
Goods and ServicesMedical and scientific research; providing medical and scientific research information in the field of clinical trials

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateSunday, February 17, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameREBIOTIX, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRoseville, MN 55113

Party NameREBIOTIX, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRoseville, MN 55113

Trademark Events


Event DateEvent Description
Monday, March 1, 2021ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 1, 2021ABANDONMENT - NO USE STATEMENT FILED
Tuesday, August 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, August 9, 2020EXTENSION 2 GRANTED
Tuesday, July 21, 2020EXTENSION 2 FILED
Sunday, August 9, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 21, 2020TEAS EXTENSION RECEIVED
Friday, January 24, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 22, 2020EXTENSION 1 GRANTED
Wednesday, January 22, 2020EXTENSION 1 FILED
Wednesday, January 22, 2020TEAS EXTENSION RECEIVED
Tuesday, July 23, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 28, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 28, 2019PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, April 18, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 17, 2019EXAMINER'S AMENDMENT ENTERED
Wednesday, April 17, 2019ASSIGNED TO LIE
Tuesday, April 16, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, April 16, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, April 16, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, April 8, 2019ASSIGNED TO EXAMINER
Thursday, March 21, 2019NOTICE OF DESIGN SEARCH CODE E-MAILED
Sunday, February 17, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, January 29, 2019NEW APPLICATION ENTERED IN TRAM